Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Nanologix Inc (NNLX) Message Board

About the N-Assay patent: US Patent 9034583 F

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 9144
Posted On: 08/12/2016 1:22:03 PM
Posted By: kcheung
Re: Eudius #2390
About the N-Assay patent: US Patent 9034583

From the paper: http://www.hindawi.com/journals/idog/aip/5293034/
Conflict of Interest: The authors report no financial interest in Nanologix, Inc. Dr. Jonath

Conflict of Interest: The authors report no financial interest in Nanologix, Inc. Dr. Jonathan Faro

20 is named as a co-inventor of the ELISA method utilized in this study, Patent 9034583, granted

21 May 19,2015.

http://www.freepatentsonline.com/9034583.html
Rapid enzyme-linked immunosorbent assay for detection and identification of pathogens and determination of antimicrobial susceptibility

United States Patent 9034583
Abstract:The present invention provides a rapid, highly sensitive and specific enzyme-linked immunosorbent assay (ELISA), referred to as N-Assay, a device, and a kit, for detection and identification of microorganisms in a sample, in thirty minutes or less, with little or no interference from non-target microorganisms. The present invention also provides for simultaneous determination of antimicrobial susceptibility of microorganism in the N-Assay.


............................................................................................................................................................................................................
About the Journal and title of the paper: (dates received and accepted)

Hindawi Publishing Corporation is one of the world’s largest publishers of peer-reviewed, fully Open Access journals. Hindawi’s journals maintain the highest standards of peer review, managed by independent academic Editors from prominent institutions around the world. Hindawi’s journals are indexed in the leading abstracting and indexing databases, including the Web of Science, Scopus, PubMed, INSPEC, Mathematical Reviews, and Chemical Abstracts.
Hindawi is a member of several industry organizations, including the Association of Learned and Professional Society Publishers (ALPSP), the International Association of Scientific, Technical and Medical Publishers (STM), the Open Access Scholarly Publishers Association (OASPA), the Committee on Publication Ethics (COPE), the International Digital Publishing Forum (IDPF), the National Information Standards Organization (NISO), the Publishers International Linking Association (Crossref), the Open Researcher and Contributor ID (ORCID), and Counting Online Usage of Networked Electronic Resources (COUNTER).

All of Hindawi’s content is archived in Portico, which provides permanent archiving for electronic scholarly journals, as well as with the LOCKSS initiative. In December 2006, Hindawi was certified with the ISO 9001:2000 quality management system by TÜV Rheinland, and this was updated to ISO 9001:2008 by BSI.

Contact Information

Email: hindawi@hindawi.com

Research Article

Development of a novel test for simultaneous bacterial identification and antibiotic susceptibility

Jonathan Faro, Malika Mitchell, Yuh-Jue Chen, Sarah Kamal, Gerald Riddle, and Sebastian Faro

Received 13 May 2016; Accepted 10 August 2016

..............................................................................................................................................................






(7)
(0)




Nanologix Inc (NNLX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us